Objectives: Synthetic biphasic calcium phosphate (BCP) with a hydroxyapatite/ß-tricalcium phosphate (HA/ß-TCP) ratio of 60/40 (BCP60/40) is successfully used as alternative for autologous bone in patients undergoing maxillary sinus floor elevation (MSFE) for dental implant placement. A high percentage of HA in BCP60/40 may hamper efficient scaffold remodeling. Osteogenesis and neovascularization are pivotal in effective bone regeneration. We aimed to investigate whether differences exist in osteogenic and/ or vasculogenic potential of BCP60/40 and BCP20/80 in patients undergoing MSFE.
| INTRODUC TI ON
Maxillary sinus floor elevation (MSFE) is a frequently performed surgical procedure to restore insufficient jaw bone height in the posterior maxilla allowing dental implant placement (Wallace & Froum, 2003; Zijderveld, van den Bergh, Cune, ten Bruggenkate & van Waas, 1997) . Autologous bone is the golden standard for clinical bone augmentation in MSFE (Zijderveld, Zerbo, van den Bergh, Schulten & ten Bruggenkate, 2005) , because it has osteoconductive as well as osteoinductive properties, contains osteogenic cells, and does not evoke immunogenic responses. Drawbacks of using autologous bone are, for example, limited availability of bone grafts and morbidity at the donor site (Klijn, Meijer, Bronkhorst & Jansen, 2010 ). An alternative to the golden standard is biphasic calcium phosphate (BCP) containing hydroxyapatite (HA) and ß-tricalcium phosphate (ß-TCP). BCP is used as bone substitute material for dental and orthopedic applications. The chemical composition of BCP resembles the inorganic part of the natural bone matrix (Frenken et al., 2010) . HA is rigid, brittle, and hardly resorbed after application in MSFE, while ß-TCP degrades faster and has a different resorption pattern (Fujita, Yokoyama, Kawasaki & Kohgo, 2003) . Furthermore, mesenchymal stromal cells on ß-TCP form more bone than mesenchymal stromal cells on HA (Prins, Fernandes, et al., 2016; Yuan et al., 2010) , which can be caused by differences in spatial distribution of bone-forming cells on HA and ß-TCP (Prins, Fernandes, et al., 2016) . For efficient scaffold remodeling, there should be a proper balance between the resorption time of the scaffold and the timing of new bone formation. BCP with a HA/ß-TCP ratio of 60/40 (BCP60/40) represents the slowest resorbing variant of BCP currently used in the clinic, while a bone substitute with 100% ß-TCP has the shortest resorption time and may lose its scaffolding properties too early. Several studies have evaluated and compared bone substitutes with different HA/ß-TCP ratios against autologous bone or each other (Hallman & Thor, 2008; Kunert-Keil, Scholz, Gedrange & Gredes, 2015; Miron et al., 2016; Schmitt et al., 2013; Tadjoedin, de Lange, Bronckers, Lyaruu & Burger, 2003; Zijderveld et al., 2005) .
Up to now, two animal studies have been published comparing BCP60/40, BCP with a HA/ß-TCP ratio of 20/80 (BCP20/80), and other bone substitutes with autologous bone (Jensen, Bornstein, Dard, Bosshardt & Buser, 2009; Yang et al., 2013) . One comparative study on BCP with different HA/ß-TCP ratios in mandibular bone defects in minipigs showed that BCP20/80 results in similar bone formation as autologous bone after 52 weeks (Jensen et al., 2009 ).
This study also showed that BCP60/40 results in similar bone formation as deproteinized bovine bone mineral (Jensen et al., 2009 ).
Another comparative study on BCP with different HA/TCP ratios in a calvarial bone defect in rabbits demonstrated that BCP60/40 and BCP20/80 provided more newly formed bone and increased bone density compared to pure ß-TCP after 8 weeks (Yang et al., 2013) .
The same study also showed that BCP60/40 and BCP20/80 exhibit similar bone healing and biodegradation patterns after this period (Yang et al., 2013) . BCP60/40 is successfully used as alternative for autologous bone in patients undergoing MSFE for dental implant placement; however, the high percentage of HA in BCP60/40 may hamper efficient scaffold remodeling. Whether BCP20/80 is more desirable to use as an alternative for autologous bone in patients undergoing MSFE for dental implant placement compared to BCP60/40 is still unclear as to the best of our knowledge BCP20/80
has not been tested before in a clinical human model.
A novel bone substitute should offer a framework for regenerating and healing of the host bone as well as formation of blood vessels. Osteogenesis and angiogenesis are tightly coupled processes, and vascular development needs to be induced before osteogenesis can take place. A comparative study of HA, TCP, and BCP60/40 in subcutaneous tissue under the thin skin muscle of the subscapular region in rats for up to 30 days showed that BCP60/40 results in similar vascularization as the TCP group after 15 days, whereas the vascularization in the BCP60/40 group is comparable as the HA group at the end of the study (Ghanaati et al., 2012) . Whether BCP20/80 enhances vascularization compared to BCP60/40 is still unclear.
As implantation of BCP with different HA/TCP ratios in patients undergoing MSFE for dental implant placement may influence the in vivo tissue reaction, we aimed to investigate whether differences exist in osteogenic and/or angiogenic potential of BCP60/40 or BCP20/80 in patients undergoing MSFE. We hypothesized that the use of BCP20/80 in human MSFE results in an increased bone volume and/or improved bone structure and/or enhanced vascularization compared to the widely used BCP60/40. In this study, we report the first comparison of BCP60/40 and BCP20/80 for osteogenic and vasculogenic potential in patients undergoing MSFE.
| MATERIAL AND ME THODS

| Biphasic calcium phosphate scaffolds
Two types of calcium phosphate scaffolds were used: (i) Straumann overruling the compositional effects due to differences in manufacturing techniques, the two BCPs were produced by the same company and had similar particle size (500-1000 μm), microporosity (2%), interconnected pores (100-500 μm), and porosity (90%).
BCP20/80 had a crystal size of 1.0-6.0 μm and a specific surface
bone regeneration, bone substitutes, clinical research, clinical trials, guided tissue regeneration, morphometric analysis, sinus floor elevation area of 9.5 × 10 −3 m 2 /g, while BCP60/40 had a crystal size of 0.6-6.0 μm and a specific surface area of 6.9 × 10 −3 m 2 /g. Characteristics and surface morphology have been described earlier (van Esterik, Zandieh-Doulabi, Kleverlaan & Klein-Nulend, 2016).
| Patient selection
The number of patients assessed for sinus floor elevation on request of the referring dentist was 26. Six patients were excluded, four patients due to insufficient native alveolar residual bone height and two patients due to heavy smoking. Twenty patients, who were partially edentulous in the posterior maxilla and required dental implants for prosthetic rehabilitation, were included consecutively in a defined period between June 2008 and August 2011, and therefore, a sample size calculation was not considered.
All patients had an adequate alveolar residual bone height at the posterior maxilla of at least 3.1 mm (Table 1) . Therefore, a preoperative panoramic radiograph was made and carefully examined for contour lines of the maxillary sinus floor and to determine the residual bone height at the planned dental implant positions. The average age of the patients was 53 years, 14 years (mean, SD). Four females (54 years, 21 years; mean, SD) and six males (54, 10) undergoing MSFE were treated with BCP60/40, and seven females (46, 10) and three males (66, 9) undergoing MSFE were treated with BCP20/80 (Table 1) . One female had natural remaining dentition, and three females and six males treated with BCP60/40 had partial remaining dentition (Table 1) . In patients treated with BCP20/80, two females had natural remaining dentition, and five females and three males had partial remaining dentition (Table 1) .
The dental restorative treatments in the BCP60/40 group were six single crowns, three blocked crowns, and one bridge (Table 1 ). In the BCP20/80 group were the dental restorative treatments seven single crowns, two blocked crowns, and one bridge ( 
| Maxillary sinus floor elevation
All 20 patients underwent a unilateral MSFE procedure as previously described (Tatum, 1986) . Briefly, a preoperative clinical photograph was taken (Figure 1a) , and a lateral bony window was prepared and to dental implant placement, a panoramic radiograph was made to determine the increase in vertical bone plus bone substitute height at the planned dental implant positions ( Figure 1b ).
| Dental implant surgery
Six and a half months, 0.9 months (mean, SD) after the MSFE procedure, dental implant surgery was performed under local anesthesia.
A crestal incision was made with mesial and distal buccal vertical release incisions. A full-thickness mucoperiosteal flap was raised to expose the underlying alveolar ridge, which was inspected for sufficient bone volume for the intended dental implant placement. Then, implant bed preparations were made and biopsies were collected with a hollow Straumann ® trephine drill (Institute Straumann AG)
with an outer diameter of 3.5 mm and an inner diameter of 2.5 mm, and using sterile saline for copious irrigation. Straumann ® dental implants (Institute Straumann AG) with a diameter of 4.1 mm, a length of 10 or 12 mm, and a sand-blasted, large-grit, acid-etched surface were placed in the augmented maxillary sinus. Dental implants were placed in a single-stage surgical procedure, mounted with healing abutments (radiograph in Figure 1c ), and sutured with Gore-Tex sutures. Immediately after dental implant placement, another panoramic radiograph was made to check dental implant placement. The panoramic radiographs taken pre-MSFE, as well as before dental implant placement, were used for morphometric measurements to determine the increase in vertical bone plus bone substitute height at the planned implant positions, using digital software. Calculations were performed with the use of a conversion factor (1.25 x) that adjusted for magnification of the panoramic radiograph. Sutures were removed after 10-14 days. Patients were instructed to avoid loading of the dental implants during the postimplant surgical osseointegration time. After a 3-month osseointegration period, the superstructures were manufactured and placed. The follow-up time for BCP60/40 was ≥ 59 months and for BCP20/80 was ≥ 58 months.
| Biopsy analysis
The bone biopsies taken during dental implant surgery with a hollow Straumann ® trephine drill were fixated in 4% phosphate-buffered formaldehyde solution (Klinipath BV, Duiven, the Netherlands) for at least 24 hr, removed from the drill, transferred to 70% ethanol, and stored until use for micro-CT analysis and histomorphometrical analysis, as described below. For each patient, one biopsy was selected in the middle of the grafted area to exclude the effect of surrounding bone containing mechanically loaded dental elements and bone near the nasal wall of the maxillary sinus.
| Micro-CT analysis
Three-dimensional biopsy reconstructions of biopsies kept in 70%
ethanol were obtained with a high-resolution micro-CT system PX5-925EA (μCT 40; Scanco Medical AG, Bassersdorf, Switzerland).
To this end, we fixed biopsies in synthetic foam, placed vertically in a custom-made polyetherimide holder, and scanned them at an 
| Histology and histomorphometrical analysis
After micro-CT scanning and dehydration in ascending alcohol series, the bone specimens were embedded without prior decalcification in low-temperature polymerizing methyl methacrylate (MMA;
Merck Schuchardt OHG, Hohenbrunn, Germany, catalogue number 8.00590.2500). Longitudinal sections of 5 μm thickness were prepared with a Jung K microtome (Reichert Jung, Heidelberg, F I G U R E 2 Methods of micro-computed tomography and histomorphometrical analyses of bone biopsies. Bone biopsies are removed from the hollow burr and analyzed using (a) micro-computed tomography and (b) histomorphometry. (c) Schematic diagram for microcomputed tomography and histomorphometrical analyses. Biopsies were analyzed separately, starting from the caudal side of the biopsy and continuing toward the cranial side. Regions of interest (ROIs) of 1 mm 2 were defined, and to obtain more insight into where the bone was formed within the grafted area, ROIs were numbered in a consecutive sequence starting from the sinus floor up to the most cranial part of the biopsy. The transition zone (tz) indicates the first ROI where substantial graft material (> 1% graft volume per total volume) was observed when analyzing the biopsy from the caudal to cranial side. Native bone (nb) is located before the tz (ROI 1). Depending on the length of the biopsy, we divided the ROIs after the tz in region I, region II, and region III. The number of ROIs in region I was 1 to 2; in region II, it ranged from 0 to 3, and in region III, it ranged from 0 to 2. For nb, tz, and each ROI, bone volume over total tissue volume (BV/TV) and graft volume over total tissue volume (GV/TV) were calculated and compared between the BCP60/40 group and BCP20/80 group Germany). Midsagittal histological sections of each biopsy were stained with Goldner's trichrome to distinguish mineralized bone tissue (green) and unmineralized osteoid (red) (Plenk, 1989) . and compared between the BCP60/40 group and BCP20/80 group. and GraphPad Prism ® 5.0 (GraphPad Software Inc., La Jolla, USA).
| Statistical analysis
| Study approval
The use of calcium phosphate ceramics (alloplastic bone substitutes) for MSFE is an accepted grafting method (Katsuyama & Jensen, 2011) . As the study involved CE-marked devices (calcium F I G U R E 3 Micro-computed tomography analysis of biopsies taken after maxillary sinus floor elevation with BCP60/40 or BCP20/80. (a) Bone volume over total tissue volume (BV/TV) and (b) graft volume over total tissue volume (GV/TV) as assessed by micro-computed tomography analysis retrieved after maxillary sinus floor elevation with BCP60/40 or BCP20/80. BV/TV and GV/TV were assessed for native bone, transition zone, region l, region ll, and region lll. Values are mean, SD (n = 7-10). *Significantly different from BCP60/40, p < .025. BCP60/40, biphasic calcium phosphate with a hydroxyapatite/ß-tricalcium phosphate ratio of 60/40; BCP20/80, biphasic calcium phosphate with a hydroxyapatite/ß-tricalcium phosphate ratio of 20/80; BV, bone volume; TV, total volume; GV, graft volume; nb, native bone; tz, transition zone; Rl, region l; Rll, region ll; Rlll, region lll phosphates) being used for their intended purpose, to be used as carrier material for bone augmentation in MSFE procedures, no specific regulatory approval from a medical ethical committee was required. The study was performed in accordance with the principles of the Declaration of Helsinki. Informed consent was obtained from all patients before the study-related procedures were undertaken.
| RE SULTS
| Clinical evaluation and implant survival
All 20 patients with a healthy periodontium showed no adverse events/complications during and after the MSFE procedure. The augmentation height increased after the MSFE procedure, and the increase was similar in the BCP60/40 group (6.1 mm, 1.7 mm (6.3 mm, 1.6 mm) (mean, SD (median, interquartile range))) and the BCP20/80 group (6.5 mm, 1.6 mm (6.5 mm, 2.7 mm)). Wound healing went uneventful, and no implants were lost after implantation.
| Micro-CT analysis
Micro-CT analysis was performed to determine bone volume over total tissue volume (BV/TV; Figure 3a ) and graft volume over total tissue volume (GV/TV; Figure 3b ). Bone volume decreased from the sinus floor toward the cranial side of the biopsies and increased at the most cranial side. The percentages of BV/TV in the grafted area were similar for all regions in the BCP60/40 group and BCP20/80 group (Figure 3a) . (Figure 3b ). GV/TV remained constant throughout the more cranial side of the biopsies from both BCP groups (BCP60/40; region l: 12.6%, 4.9% (12.6%, 7.3%) (mean, SD (median, interquartile range)), region ll: 11.6%, 7.5% (14.6%, 11.2%), region lll: 12.1%, 7.6% (15.2%, 7.8%), and BCP20/80; region l: 13.4%, 7.8%
(15.9%, 12.3%), region ll: 14.1%, 3.9% (13.6%, 5.3%), and region lll:
11.4%, 5.5% (14.0%, 5.9%); Figure 3b ).
| Histology and histomorphometrical analysis
Histomorphometrical analysis was performed to determine bone ingrowth (in graft area, tz is not included), bone volume over total The number of blood vessels was counted to study blood vessel formation in biopsies taken after maxillary sinus floor elevation with BCP60/40 or BCP20/80. Depending on the size, blood vessels were defined as small (0-400 μm 2 ), medium (401-1200 μm 2 ), or large (>1200 μm 2 ) blood vessel. No differences in number of small, medium, or large blood vessels could be observed in the BCP20/80 group compared to the BCP60/40 group (Table 2) .
| D ISCUSS I ON
This study aimed to investigate whether differences exist in osteogenic and/or vasculogenic potential of BCP60/40 and BCP20/80 in patients undergoing MSFE. We found that (i) the bone ingrowth (in mm) from the native bone toward the cranial side of the biopsy was similar in both BCP groups; (ii) BV/TV was 9.7% higher in the BCP20/80 group than the BCP60/40 group at the most cranial side of the biopsy (histomorphometry); (iii) GV/TV was similar in both BCP groups in all regions; (iv) OV/TV was 0.8% higher in the BCP20/80 group than in the BC60/40 group at the most cranial side of the biopsy (histomorphometry); (v) the number of TRAcP-positive osteoclasts was similar in both BCP groups; and (vi) no differences in of the biopsy in this study was lower for both BCP groups. The difference in bone ingrowth speed might be explained by the different method used for numbering of the regions of interest or by the time point of dental implant placement. In the present study, dental implants were placed 6.5 months (26 weeks) after the MSFE procedure, while in our previously published bilateral sinus elevation procedure study, the dental implants were placed 3 to 8 months after the MSFE procedure (de Lange et al., 2014) . HA is rigid, brittle, and hardly resorbed, while ß-TCP degrades faster and has a different resorption pattern (Fujita et al., 2003) . The lower the HA/ß-TCP ratio, the more the dissolution of BCP (LeGeros, 1993) . Based on the lower HA/ß-TCP ratio in BCP20/80, a higher resorption rate in BCP20/80-grafted biopsies than in BCP60/40-grafted biopsies was expected, but this observation was not observed. As we only analyzed biopsies after a short term (up to 6 months), a higher resorption rate in BCP20/80-grafted biopsies may be observed in the long term (> 6 months). A higher resorption rate in BCP20/80-grafted biopsies would allow more space for new bone ingrowth as well as blood vessel formation in the BCP20/80 group. The micro-CT and histomorphometrical analyses showed similar bone formation from the native bone toward the cranial side in the biopsies of both BCPs; but although micro-CT analysis showed a similar trend, only histomorphometrical analysis resulted in significant more bone formation in the BCP20/80 group at the most cranial side of the biopsy. The same pattern as found for bone formation was observed for osteoid deposition in the grafted areas. Active bone formation at the cranial side of the biopsies has also been observed in our clinical trial, where patients undergoing bilateral MSFE were treated with ß-TCP or BCP60/40 with and without freshly isolated autologous stromal vascular fraction (SVF) of adipose tissue containing multipotent cells (Prins, Schulten, ten Bruggenkate, Klein-Nulend & Helder, 2016) . In that study, more active bone formation was observed at the cranial side of the biopsies with SVF than without SVF, which might be due to transdifferentiation of adipose stem cells within the SVF toward bone-forming cells or caused by increased adipose stem cell paracrine recruitment of progenitor cells from the lateral bony window capping the bone reconstruction compartment and/or the human Schneiderian membrane of the maxillary sinus. It has recently been shown that this membrane, which is lifted during MSFE to insert the graft material, contains a cell population with potential for osteogenic differentiation (Berbéri et al., 2016) . As in our study we did not include multipotent cells on the scaffolds, the observed high bone volumes in the most cranial side of the biopsies may be due to bone ingrowth from the cranial side from this membrane or lifted lateral bony window. The noted divergence between the levels of bone ingrowth between both BCP types, with the HA/ß-TCP ratio being the only parameter being different, suggests that a higher TCP content may positively contribute to the bone ingrowth rate. This is in line with a previous study showing that TCP has a relatively late-occurring remodeling phase, supports cell ingrowth, and promotes osteogenic differentiation of osteoprogenitor cells (Zerbo, Bronckers, de Lange & Burger, 2005) . Moreover, the findings in our study support the suggestion to keep the lateral bony window of the maxillary sinus in situ (Prins, Schulten, et al., 2016) . Comparison of our data with other studies using a variety of biomaterials is rather difficult as a large heterogeneity exists in bone formation among several studies using bovine bone, autologous bone, HA, TCP, BCP, and calcium sulfate (Corbella, Taschieri, Weinstein & Del Fabbro, 2016) .
The results from the micro-CT and histomorphometrical analyses showed a similar trend in remaining graft volumes in both BCP groups, but a lower percentage of graft volume was observed by micro-CT analysis than our histomorphometrical analysis. A similar discrepancy was found in our previous studies (Prins, Schulten, et al., 2016; Schulten et al., 2013) and can be explained by the fact that micro-CT analysis comprises three-dimensional measurements, while histomorphometrical analysis comprises two-dimensional measurements.
During histological preparation, graft material is dissolved, which gives the false impression that the granules are solid while being porous.
Despite the differences in data obtained by micro-CT and histomorphometrical analyses, they seem to complement each other; micro-CT analysis is based on differences between structures and mineralized compounds, while histomorphometrical analysis provides information on, for example cells, and soft tissue organization and structure.
We found similar numbers of TRAcP-positive osteoclasts laying against bone matrix in the BCP60/40 group and the BCP20/80 group in all regions, but lower numbers of osteoclasts were observed in the BCP20/80 group than the BCP60/40 group for the grafted area.
The micro-CT and histomorphometrical analyses showed more bone formation and subsequent bone remodeling in the BCP20/80 group, thus explaining the lower number of osteoclasts we found at the time point of our analysis. HA is degraded by osteoclastic resorption, and more TRAcP-positive cells are present on HA disks than on β-TCP disks (Lee et al., 2014) . Therefore, the lower percentage of HA in BCP20/80 compared to BCP60/40 may explain the lower number of osteoclasts we observed in the BCP20/80 group.
Bone is highly vascularized, and vascular development needs to be induced prior to osteogenesis. Both BCP60/40 and BCP20/80 in patients undergoing MSFE apparently had sufficient and comparable angiogenic potential to form new bone. In contrast, in our clinical trial where 6/10 patients underwent bilateral MSFE and were treated with either ß-TCP or BCP60/40 with and without freshly isolated autologous SVF of adipose tissue, bone formation could be linked to increased blood vessel formation (Prins, Schulten, et al., 2016; Farré-Guasch et al., 2013 . The SVF consists of a heterogeneous mixture of cells including endothelial cells and lineage-committed progenitor cells (Zuk et al., 2001 (Zuk et al., , 2002 . This suggests that freshly isolated autologous SVF of adipose tissue may trigger increased blood vessel formation, which will allow nutrient diffusion and waste removal crucial for cell recruitment, survival, proliferation, differentiation, and tissue remodeling. It seems that freshly isolated autologous SVF of adipose tissue increases nutrient delivery, enabling more cell penetration toward the interior of the grafted area, and thus faster tissue remodeling compared to our current study without cells. SVF fits in a so-called one-step surgical procedure (Farré-Guasch et al., 2013) .
Our results suggest that SVF-seeded BCP20/80 might perform better than SVF-seeded BCP60/40 in the MSFE model during a one-step surgical procedure. Further preclinical in vivo studies are needed before clinical implantation can be considered.
A limitation of the present study is that we compared two BCPs using biopsies from unilateral sinus floor elevation in different patients.
As the anatomical structure of the maxillary sinus varies between patients, bilateral sinus floor elevation models would be more appropriate to compare two BCPs. Another limitation of the present study is that we only analyzed biopsies after a short term, while BCP60/40 may have a beneficial long-term outcome due to a lower resorption rate. In future studies, BCP60/40 and BCP20/80 should be compared in bilateral sinus floor elevation models to eliminate the variation in anatomical structure of the sinus between patients after a longer healing period.
In summary, the use of BCP20/80 in human MSFE resulted in a 9.7% higher bone and 0.8% osteoid volume at the cranial side of the biopsies than BCP60/40, but no differences in vascularization could be observed. Therefore, we conclude that BCP20/80 showed enhanced osteogenic potential in patients undergoing MSFE compared to BCP60/40, due to a faster bone remodeling rate, or an earlier start of bone remodeling in BCP20/80-treated patients, suggesting that a higher TCP content positively contributes to the bone remodeling rate. This demonstrates that BCP20/80 might perform better as a scaffold for bone augmentation in the MSFE model than BCP60/40 in the short term as more bone is formed, and more osteoid is deposited at the cranial side in BCP20/80-treated patients compared to BCP60/40-treated patients. 
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